Background: Myrtus communis L. (MC) is widely used as an antidiabetic plant in folk medicine. This study aimed to analyze the possible antidiabetic and hepatoprotective effects of MC berries in streptozotocin (STZ)induced diabetic rats.
I. Introduction
Diabetes mellitus (DM) is a chronic metabolic disorder affecting many people around the world. The disease is characterized by altered blood glucose levels, carbonhydrate, lipid and protein metabolism defects and complications including hepatopathy, nephropathy and neuropathy. As the disease has deleterious effects on the health status of individuals and large numbers are affected, the socio-economic consequences of the disease can impact the productivity of nations 1 .
A disproportion between reactive oxygen species generation and free radical scavenging systems causes oxidative stress in the body. In DM, reactive oxygen species (ROS) production is elevated and the resulting oxidative stress is closely related with DM complications 2 . Superoxide anion, MDA and oxide glutathione are indicators of oxidative stress. Chronic accumulation of ROS in hyperglycemia plays a pivotal role in the development of liver injury. Antioxidant drugs and plants with antioxidant properties have been reported to be benefical in reducing or recovering DM-related liver injury 3 .Therefore, there is growing interest in herbal medicine for the treatment of DM 4 . Myrtus communis L. (MC) is an endemic plant in the Mediterranean region, which is widely grown and used in west and south Anatolia. Various parts of MC are used in folk medicine. In vitro and animal studies have demonstrated a wide range of activities, including antidiabetic, anti-inflammatory, analgesic, antiviral, antimutagenic and cardiovascular effects 5 .
To date, animal studies have been conducted to demonstrate the antidiabetic effects of MC by inducing Type II DM either with streptozotocin (STZ) or alloxan 4, 6, 7 . Although there is considerable evidence about the antidiabetic effects of MC, the underlying mechanism of the hypoglycemic effect is unclear. Some researchers have suggested that the effects of MC on glucose metabolism can be summarized as activation of degradation pathways and inhibition of production pathways 4 .
Thus, MC can be considered as a possible candidate antidiabetic agent due to its high antioxidant and hepatoprotective effects. This study was designed to investigate the possible antidiabetic effects of MC berries on rats in a diabetic condition induced by STZ.
II. Methods

Plant material and extract preparation
The botanical identification was made according to international identification methods by a professional botanist. The berries were mechanically powdered by liquid nitrogen, and extracted with pure water six times. The obtained extracts were filtered and combined, and the solvent was evaporated. The extract was diluted in pure water and administered to the rats with intragastric gavage.
Experimental Animals
The study was approved by and conducted in accordance with the local Institutional Animal Care and Use Committee, under protocol no. 128. All animals were housed in facilities approved by international guidelines. During the experimental period, all rats received a normal chow diet and drinking water ad libitum.
Induction of diabetes mellitus
STZ was dissolved in citrate buffer (0.1 mol/L, pH:4.5). Type II Diabetes mellitus was induced with STZ solution at a single dose of 40 mg/kg body weight. Three days after DM inducement, administration of aqueous extract of MC berries began and lasted for 14 days. Blood samples were obtained from the tail vein and rats with a glucose level ≥200 mg/dl were accepted as DM and included in the study 8 .
Experimental Design
A total of thirty 6-week-old male Albino Wistar rats (weighing 200-220 g) were randomly divided into 6 groups of 5: Group I = normal control; Group II = DM control; Group III = 1000 mg/kg MC extract; Group IV =DM+250 mg/kg MC extract; Group V = DM+500 mg/kg MC extract; Group VI = DM+1000 mg/kg MC extract. The animals were sacrificed by cervical dislocation. Cardiac blood samples were obtained and the livers were removed.
Serum Samples and Biochemical Tests
Blood glucose levels were measured by a glucometer (Accu-Chek Active) and respective dry reagent test-strips based on the glucose oxidase technique. Serum aspartate aminotransferase (AST), alkaline phosphatase (ALP) and alanine aminotransferase (ALT) levels were measured using an automatic biochemical and immune-enzyme analyzer (GBG ChemWell 2990,USA) with commercially availabe enzyme kits.
Production of liver homogenate and measurement of oxidative stress parameters
The liver tissues were ground with liquid nitrogen in a mortar. The tissues were treated with HEPES buffer for superoxide dismutase (SOD) and RIPA buffer for malondialdehyde (MDA) measurement and then homogenized on ice by an Ultra-Turrax homogenizer at 9500 rpm. The supernatans obtained from centrifugation of homogenates were used to determine SOD and MDA levels with ELISA kits produced for rats (Cayman Chemical and TBARS Assay STA-330 respectively).
The reduced glutathione (GSH) levels in the liver tissues were determined according to the method of Sedlak and Lindsay 9 . For this assay, 2 mL of 50mM Tris-HCl buffer containing 20mM EDTA and 0.2M sucrose, pH 7.5 was used to homogenize the liver tissue. The homogenate was centrifuged at 4200 rpm for 40 min at 4 °C, and then the supernatant was used to determine GSH using 5.5-dithiobis (2-nitrobenzoic acid). GSH concentration was determined by spectrophotometer at 412 nm. SOD activity and serum GSH and MDA levels were expressed as U/mg tissue, μM/mg tissue,and μM/mg tissue respectively.
Chemicals
Streptozotocin (C8H15N3O7) (STZ) was obtained from Sigma Aldrich (Sigma, USA). All other chemicals and analytical grade solvents were of the highest quality available and were purchased from Merck Chemicals (Germany). Purified double distilled water was used for the analytical procedures.
Statistical analysis
Statistical analysis was performed using the SPSS 20.0 program (SPSS Inc., Chicago, IL, USA). Data were presented as mean and standard deviation (mean±SD 
III. Results
Effects of MC berries extract on blood glucose levels
The blood glucose levels of the control, diabetic control and diabetic treated with MC extract groups are given in Table 1 . Blood glucose levels were significantly and 3.4 times higher in the diabetic model (diabetic control) group compared to the control group (p<0.001). Although blood glucose levels were slightly higher in the MC extract only (1000 mg/kg) administrated group compared to the control group, this elevation was not significant (p>0.05). The blood glucose levels were significantly decreased by oral administration of all doses (250 mg/kg, 500 mg/kg, 1000 mg/kg) of aqueous extract of MC (p<0.05, p<0.05, p<0.001 respectively) ( Table  1 ). The 1000 mg/kg dose of MC extract was determined to be more effective than the other doses in reducing blood glucose levels.
Effects of MC berries extract on liver enzymes
Serum ALT, AST and ALP levels were significantly higher in the diabetic model (diabetic control) group compared to the control group (p<0.01 for all parameters). The oral administration of MC berries extract at 1000 mg/kg dose provided a non-significant decrement in serum ALT, AST and ALP levels compared to the control group (p>0.05 for all parameters).
The administration of MC extract to the diabetic groups provided a significant improvement in serum ALT, AST and ALP levels compared to the control group (p<0.01 for all parameters).
Effects of MC berries extract on liver oxidant-antioxidant status
The oxidant-antioxidant status of the liver was evaluated by determining the levels of SOD activity, MDA and GSH levels ( Table 3 ). The induction of DM caused a significant (p<0.001) elevation in MDA and a significant decrement in both SOD and GSH in the diabetic model (diabetic control) group compared to the control group (p<0.001). There were no significant differences in terms of SOD activity, GSH and MDA levels in the MC treated (1000 mg/kg) group compared to the control group (p>0.05 for all parameters).
Oral administration of MC berries extract improved oxidative stress as manifested by the significant increment in SOD and GSH (p<0.01 for both parameters) and the significant decrement in MDA levels in the diabetic model (diabetic control) group compared to the control group. This antioxidant activity was dosedependent and found to be highest at the 1000 mg/kg dose of MC aqueous extract (Table 3) . 
IV. Discussion
Changes in carbohydrate, lipid, and protein metabolisms related to DM lead to disorders in many organs and metabolisms 10 . Liver disease prevalance in DM patients is high 11 . Although the underlying mechanism is not clear, it is known that there is a relationship between insulin signaling and hepatocellular damage 12 . Altered blood glucose levels may cause inequality in redox reactions 13 . It is also known that STZ has adverse effects on the liver 14, 15 . Histopathological studies have demonstrated that the liver was necrotized in diabetic rats 16 .
ALT, AST and ALP are liver enzymes and the altered serum levels of these enzymes arises from a possible leakage of enzymes from hepotocytes into the blood stream. Therefore, elevated serum AST, ALT and ALP levels are considered a sign of hepatic injury [17] [18] [19] .
In the current study, MC administration provided a significant decrease in the AST, ALT and ALP activities of diabetic rats, as has been previously reported 20, 21 . It is presumed that MC extract prevented hepatocellular damage by avoiding leakage of the enzymes from hepatocytes to the blood stream.
Blood glucose level is the most used diagnostic criteria for diabetes 22 . Previous studies have demonstrated the hypoglycemic effects of ethanol-water extract of MC and the phenolic compounds extracted from MC 6, 23 . It should be noted that, these studies reported the hypoglycemic effects of MC extract and its components only on diabetic animals, and the extract and its components did not show any hypoglycemic effects on normoglycemic animals 6 . Similar to these studies, the results of the current study showed that although there was a slight alteration in the blood glucose level in the MC extract 1000 mg/kg group, compared to the normal control group, this alteration was not significant. The administrated doses of MC showed a hypoglycemic effect in diabetic rats ,being highest at the dose of 1000 mg/kg. This dose value was close to previously reported effective doses of extracts and compounds of MC. Future studies will be conducted on doses close to 1000 mg/kg to determine the accurate hypoglycemic dose of MC berries.
It is known that production of reactive oxygen species (ROS) as a result of oxidative stress accompanies DM due to the auto-oxidation of excessive glucose 24 . In fact, there is considerable evidence about the oxidative stress inducing potential of STZ 25 . Once excessive free radicals are formed, they diffuse into cells and form mitochondrial enzyme injury and DNA fragmentations, which lead to cellular damage and complications of DM 26 . Supporting these findings, approaches aiming to treat DM complications with antioxidant molecules and plants are based on the oxidative stress mechanism of DM 27, 28 . GSH is a key element of the non-enzymatic antioxidant system. Diminished levels of GSH may be a result of either a reduction in its synthesis or of oxidative stress. SOD is an enzymatic antioxidant which protects cells from oxidative injury generated by ROS 29 . Lipid peroxides in the cellular membrane are metabolized to MDA in β-oxidation reactions. Elevated serum MDA levels are considered to be an indicator of cellular membrane injury caused by oxidative stress 30 .
Many studies have reported on diminished enzymatic and non-enzymatic antioxidant activities in diabetic rats 31, 32 . Oxidative stress resulting from excessive production of ROS has been suggested to be a potential mechanism involved in diabetic hepatopathy 32 and other complications 33, 34 . In the current study, the administration of aqueous extract of MC berries provided a significant improvement in the antioxidant system, namely an increment in SOD activity and GSH levels and a reduction in MDA levels. Considering that MC extract is a rich source of polyphenolic compounds which have inhibitor potential of glucose absorption from the intestines 35, 36 , it can be concluded that the antidiabetic effect of MC is based on its hypoglycemic and antioxidant properties.
In conclusion, the results of this study demonstrated that MC extract provided significant hypoglycemic and antioxidant effects on diabetic rats. It must be considered that the extract had no hypoglycemic and antioxidant effect on normoglycemic rats. Thus, the use of MC berries can be recommended complementary to antidiabetic treatment in DM patients, rather than dietary consumption of the plant by individuals at risk of DM. It is clear that the consumption of berries is more practical than the use of volatile oil or extracts of leaves which require some pre-processing steps.This preliminary study can be considered useful as guidance for further studies including SOD expression levels and those studies could help to create an antidiabetic agent from MC. The authors declare that there is no conflict of interest.
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